A novel microRNA promotes coxsackievirus B4 infection of pancreatic β cells
Author Information
Author(s): Lalani Salima, Knudsen Joseph, Kenney James, Hober Didier, DiPersio C. Michael, Gerber Allen
Primary Institution: Albany Medical College
Hypothesis
Coxsackievirus B alters the miRNA signature of pancreatic β cells, contributing to the autoimmune response that triggers type 1 diabetes.
Conclusion
Inhibiting the microRNA hsa-miR-AMC1 reduces coxsackievirus B4 infection and may increase insulin production in pancreatic β cells.
Supporting Evidence
- Treatment with an antagomir targeting hsa-miR-AMC1 led to decreased coxsackievirus B4 infection in pancreatic β cells.
- Hsa-miR-AMC1 was upregulated in pancreatic β cells following coxsackievirus B4 infection.
- Inhibition of hsa-miR-AMC1 was associated with increased insulin production in infected β cells.
Takeaway
A new microRNA helps a virus infect cells that produce insulin, and stopping this microRNA might help people with diabetes.
Methodology
The study used small RNA-sequencing and qPCR to analyze the effects of coxsackievirus B4 on pancreatic β cells and the role of hsa-miR-AMC1.
Statistical Information
P-Value
1.89E-05
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website